Furthermore, more pronounced cognitive impairment is observed in DLB APOE4 carriers when compared to non-carriers, including in attention, learning, memory, and executive function (Ballard et al., 2001; Mirza et al., 2019; Nasri et al., 2022). Here, APOE is linked to Lewy body dementia.